Researchers report pediatric patients’ hospital admissions related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a recent study that was published in The BMJ.
Although pediatric SARS-CoV-2 hospitalizations have been uncommon, infection rates have been significant, and patients with concomitant conditions are more likely to experience catastrophic COVID-19 (2019) outcomes. SARS-CoV-2 immunization rates in children have remained low at the same time.
The Office for National Statistics (ONS) revealed that between September 2021 and April 2022, children and adolescents had the greatest rates of COVID-19, and that the second COVID-19 wave had more pediatric hospitalizations than the first. However, it is still unknown what effect hospitalizations for COVID-19 have on health.
In the current statewide retrospective cohort study, researchers examined all 12 million pediatric residents of England who were hospitalized for COVID-19.
Twelve million people under the age of 18 who lived in England and had three million COVID-19 instances that had been initially determined were included in the study. Data were taken from electronic medical records between July 2020 and February 2022. Initial hospitalizations for COVID-19, with SARS-CoV-2 as a contributing factor, incidental to COVID-19, and hospital-acquired or nosocomial COVID-19 were the study’s outcomes.
The British Heart Foundation’s (BHF) COVID-IMPACT/CVD-COVID-UK partnership provided access to the National Health Service (NHS) England research settings, which were used to create a linked group of datasets. These included primary care information provided by the General Practice Extraction Service (GPES) for COVID-19 research and planning, nationwide laboratory-based SARS-CoV-2 testing data from the United Kingdom Health Security Agency (UKHSA) second generation surveillance system (SGSS), and the Hospital Episode Statistics (HES), including hospital unit, critical care unit, and outpatient care.
| Read More news: Click here |
